The hypothesis that low selenium may in some circumstances be a risk f
actor for lung cancer was investigated in a case-control study nested
within a longitudinal study. Serum samples from 9, 101 cancer-free ind
ividuals were collected and stored at -20 degrees C by the Finnish Mob
ile Clinic in 1968-1971 and 1973-1976, During follow-up until the end
of 1991, 95 cases of lung cancer were diagnosed. Selenium concentratio
ns were determined from the serum samples of the cases and 190 control
s, individually matched for sex, age, and place of residence. Mean lev
els of serum selenium in cases and controls were 53.2 mu g/liter and 5
7.8 mu g/liter, respectively. The relative risk of lung cancer between
the highest and lowest tertiles of serum selenium, adjusted for smoki
ng, serum alpha-tocopherol, serum cholesterol, serum copper, serum oro
somucoid, and body mass index (kg/m(2)), was 0.41 (95% confidence inte
rval (CI) 0.17-0.94). The association was stronger at lower levels (<5
.9 mg/liter) of alpha-tocopherol (relative risk = 0.24, 95% CI 0.07-0.
85), The association was also pronounced among current smokers and at
higher levels of serum orosomucoid and serum copper. The relative risk
for smokers who were twice ranked in higher selenium tertiles, at an
interval of 4-7 years, in comparison with smokers who remained in the
lowest tertile was 0.16 (95% CI 0.04-0.74), In accordance with the hyp
othesis, the findings suggest that very low selenium status may contri
bute to the risk of lung cancer.